Abbott Laboratories
Abbott Laboratories (ABT) Covered Calls
Abbott Laboratories trades in the Medical Devices industry with an IV Rank of 66.27%, average versus the past year. ABT's highest covered call setup is the $115.00 strike expiring Nov 20, 2026, sorted by theoretical annualized return. It's 7.03% out of the money with 4 days to expiration, a 7.07% return until expiration, and a 645.42% theoretical annualized return. Across the setups shown, annualized returns run from 200.04% to 645.42% at strikes between $110.00 and $118.00, with 4 to 18 days to expiration, as of Nov 16, 2026.
Read more
Running ABT covered calls helps you generate income from Abbott Laboratories shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best ABT covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call pairs limited risk with a clear income profile. If ABT stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling ABT covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given ABT covered call is worth writing.
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon.
| 2026-11-20 | 4 | 115.00 | 7.03 | 0.05 | 0.10 | 760.00 | 7.07 | 645.42 | -0.05 | +0.04 | 1,916 | 0.05 |
| 2026-11-20 | 4 | 113.00 | 5.17 | 0.10 | 0.20 | 565.00 | 5.26 | 479.82 | -0.09 | +0.09 | 88 | 0.10 |
| 2026-11-20 | 4 | 112.00 | 4.23 | 0.15 | 0.30 | 470.00 | 4.37 | 399.14 | -0.14 | +0.12 | 1,553 | 0.15 |
| 2026-11-20 | 4 | 111.00 | 3.30 | 0.30 | 0.50 | 385.00 | 3.58 | 326.95 | -0.28 | +0.19 | 171 | 0.20 |
| 2026-11-27 | 11 | 117.00 | 8.89 | 0.05 | 0.15 | 960.00 | 8.93 | 296.46 | -0.05 | +0.05 | 14 | 0.10 |
| 2026-11-27 | 11 | 116.00 | 7.96 | 0.05 | 0.85 | 860.00 | 8.00 | 265.58 | -0.05 | +0.13 | 94 | 0.80 |
| 2026-11-20 | 4 | 110.00 | 2.37 | 0.45 | 0.65 | 300.00 | 2.79 | 254.77 | -0.42 | +0.25 | 8,660 | 0.20 |
| 2026-11-27 | 11 | 115.00 | 7.03 | 0.15 | 0.30 | 770.00 | 7.17 | 237.79 | -0.14 | +0.09 | 163 | 0.15 |
| 2026-11-27 | 11 | 114.00 | 6.10 | 0.20 | 0.35 | 675.00 | 6.28 | 208.45 | -0.19 | +0.11 | 20 | 0.15 |
| 2026-12-04 | 18 | 118.00 | 9.82 | 0.05 | 0.30 | 1060.00 | 9.87 | 200.04 | -0.05 | +0.06 | 2 | 0.25 |
As of Nov 16, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →Stock Statistics
- IndustryMedical Devices
- SectorHealthcare
- IV Rank66.27% Moderate
- Market cap (M$)181,352
- 52 weeks high-20.69%
- 52 weeks low27.74%
- Analyst recommendationBuy
1.65 - Target price$119.46
14.09% above the current stock price - Dividend—
- Payout ratio64.54%
- Earnings date2027-01-28
- P/E38.66
- Future P/E17.66
- EPS (ttm)2.71
- EPS growth next 5 years8.08%
As of Nov 17, 2026